Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
638 studies found for:    "ulcerative colitis"
Show Display Options
RSS Create an RSS feed from your search for:
"ulcerative colitis"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Terminated Basiliximab Maintenance in Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Drug: Basiliximab
2 Active, not recruiting Special Investigation in Patients With Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention:
3 Completed Wireless Capsule Endoscopy in Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Device: Given® Diagnostic System
4 Terminated Effects of Probiotics in Patients With Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Dietary Supplement: Kyo-Dophilus;   Dietary Supplement: placebo
5 Withdrawn Lactobacillus GG in Pediatric Ulcerative Colitis (UC)
Condition: Ulcerative Colitis
Intervention: Biological: Lactobacillus GG
6 Completed Qualitative Study of Topical Mesalamine Adherence in Patients With Ulcerative Colitis(UC)
Condition: Ulcerative Colitis
Intervention:
7 Completed Study of COLAL-PRED® in the Treatment of Moderate Acute Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Drug: COLAL-PRED®;   Drug: Prednisolone
8 Completed Basiliximab in Moderate to Severe Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Drug: Basiliximab
9 Completed
Has Results
A Study of Adalimumab in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Biological: adalimumab;   Drug: placebo
10 Completed Safety, Efficacy, and Tolerability Study of ASP3291 in Patients With Active Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Drug: ASP3291;   Drug: Placebo
11 Completed Treatment of Ulcerative Colitis With Ciprofloxacin and E. Coli Nissle
Condition: Ulcerative Colitis
Interventions: Drug: Ciprofloxacin;   Dietary Supplement: E. coli Nissle
12 Active, not recruiting Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Biological: adalimumab
13 Completed Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Drug: AVX 470;   Drug: Placebo
14 Enrolling by invitation Long-term Safety and Efficacy Study of Adalimumab in Pediatric Subjects With Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Biological: Adalimumab
15 Recruiting Study to Evaluate the Safety and Efficacy of Two Drug Regimens in Subjects With Moderate to Severe Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Drug: Adalimumab;   Other: Placebo
16 Completed Study for the Treatment of Ulcerative Colitis With Adacolumn
Condition: Ulcerative Colitis
Intervention: Device: Adacolumn Apheresis System
17 Active, not recruiting AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Biological: AMG 181;   Other: Placebo
18 Terminated Propionyl-L-Carnitine Hydrochloride in Patients With Mild Ulcerative Colitis; Efficacy, Safety and Tolerability Study
Condition: Ulcerative Colitis
Interventions: Drug: Propionyl-L-Carnitine;   Drug: Placebo
19 Completed (CB-01-02/04) Extension Study of Budesonide Multi-Matrix System (MMX) 6 mg in Maintenance Of Remission In Patients With Ulcerative Colitis.
Condition: Ulcerative Colitis
Interventions: Drug: Budesonide MMX 6 mg Tablet;   Drug: Placebo Tablet
20 Completed A Study of MDX-1100 in Subjects With Active Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Biological: sterile saline for injection;   Biological: MDX-1100

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.